Cannabis and Sleep: What the Research Actually Says
Sleep is one of the most common reasons adults use cannabis — but the research tells a more complicated story than the marketing. What THC, CBD and CBN actually do to sleep, what happens with nightly use, and why stopping can be the hardest part.

- Published
- November 16, 2026
- Read time
- 7 min read
- Category
- Responsible Adult-Use
- Focus
- #sleep #research #cannabis-education
Research-Based Evidence Review
What this guide covers
Sleep is one of the most common reasons adults give for using cannabis. In a 2024 Canadian survey of 4,037 adults, 15.6% said they had used a cannabis-derived product for sleep in the past year — roughly the same share as those who had used a prescription sleep medication. So the question matters: what does the research actually show? The honest answer is more complicated — and more interesting — than "cannabis helps you sleep."
Core Research Findings
The short answer
THC can make people feel like they fall asleep faster, especially at first. But measured in sleep labs, the effects are small, inconsistent, and they fade with regular use. CBD on its own has not beaten a placebo in sleep trials. CBN, despite being marketed as the sleepy cannabinoid, has almost no clinical evidence behind it. And the most reliable sleep finding in the entire literature is an uncomfortable one: stopping after regular use disturbs sleep.
THC Sleep Mechanics
Night one: what THC actually does
In the best-known modern trial (Walsh et al., 2021, Sleep), 23 adults with insomnia took an oil with 10–20 mg THC (plus small amounts of CBN and CBD) for two weeks. In their sleep diaries, they fell asleep about 8 minutes faster. On the sleep-lab measurements, though, there was no difference at all — the benefit was in how sleep felt, not in what the instruments recorded.
Sleep-lab studies also show THC can suppress REM sleep — the dream stage. A 2026 single-dose study (Suraev et al., Journal of Sleep Research) using brain monitoring found 10 mg THC (with 200 mg CBD) cut REM sleep by about 34 minutes and delayed it by over an hour, while total sleep time actually went down by about 25 minutes. And the popular claim that THC boosts deep sleep? The evidence does not support it: a 2025 meta-analysis of sleep-lab studies (Velzeboer et al., Sleep Medicine Reviews) concluded cannabis "does not consistently alter sleep duration, latency, wake time, efficiency, or sleep staging," and an earlier controlled study found a THC+CBD combination reduced stage-3 deep sleep.
Chronic Use Effects
Night thirty: tolerance changes the picture
The sleep effects of THC fade with regular use. In a 2013 study of daily smokers given high daily THC doses, total sleep time shrank night after night even though THC levels stayed high — the authors' explanation was tolerance. Long-term data points the same way: in a 35-year follow-up of the CARDIA cohort published in 2026, recent users slept about 20 minutes longer but with more fragmented sleep, and — tellingly — reported no better sleep quality than non-users. Feeling helped and sleeping better are not the same measurement.
Withdrawal And Rebound
The hardest part: stopping
This is the most consistent finding in the research. About 47% of regular users experience cannabis withdrawal (Bahji et al., 2020, JAMA Network Open, 47 studies, 23,518 people), and disturbed sleep is one of its hallmark symptoms. Sleep-lab studies of abstinence (for example Vandrey et al., 2011) show the pattern: longer time to fall asleep, less efficient sleep, and a REM rebound — the return of intense, vivid dreams as the brain makes up for suppressed REM. Symptoms typically start within 24–48 hours, peak around days 2–6, and while most settle within one to two weeks, sleep problems can linger for several weeks. Anyone who has taken a tolerance break and slept badly for the first few nights has felt this research first-hand.
CBD Clinical Evidence
CBD: the trials are quiet
CBD is widely sold for sleep, but the controlled evidence is weak. The most-cited study (Shannon et al., 2019) was a chart review of 72 clinic patients with no placebo group; sleep scores improved in two-thirds of patients in the first month, then fluctuated — a pattern that cannot separate CBD's effect from everything else going on in those patients' care. In actual placebo-controlled trials, CBD has not separated from placebo: 300 mg did not change the sleep-wake cycle in a 2018 sleep-lab study, and 150 mg nightly for two weeks did not improve insomnia scores, sleep onset, or sleep efficiency versus placebo in a 2024 trial of 30 people with moderate-to-severe insomnia. A 2025 pooled analysis found CBD-only products had no significant effect on sleep, while the positive results came from THC-containing products. There is also no established dose-response for CBD and sleep — 15, 25, 150 and 300 mg have all produced null or uncontrolled results.
CBN Research Status
CBN: marketing ahead of evidence
CBN is sold as the sleep cannabinoid, but a 2021 evidence review found no published trial using a validated sleep measure or sleep-lab recording to support that claim. The trials have finally started — and none has hit its main target. In the largest (Bonn-Miller et al., 2024; 293 adults), 20 mg CBN missed its primary sleep-quality endpoint; in a 1,020-person trial (Kolobaric et al., 2024), CBN improved sleep scores but was no better than 4 mg of melatonin, and the responder rate was not significantly different from placebo. A 2026 sleep-lab study in diagnosed insomnia found no significant effect on waking after sleep onset at either 30 mg or 300 mg. That does not prove CBN does nothing — it proves the claim is currently running far ahead of the data.
Clinical Insomnia Findings
So does cannabis treat insomnia?
Reviews that pool only diagnosed-insomnia trials give the strictest answer. The 2026 Cochrane review (Varela et al.) — 9 randomized trials, 537 people — concluded cannabinoids "may have little to no clinically meaningful effect" on sleep quality, total sleep time, or daytime functioning in insomnia, with all efficacy findings rated very low certainty, and more adverse events than placebo. A 2020 review in Sleep Medicine Reviews similarly found insufficient evidence to support routine clinical use for any sleep disorder. Where small benefits do appear in pooled analyses, they are mostly in chronic-pain patients sleeping better as pain eases — not evidence for treating insomnia itself.
Practical Consumer Guidance
What this means if you use cannabis at night
- It is not a proven sleep treatment. Occasional perceived help falling asleep is real for many people; a reliable, lasting improvement in sleep quality is not what the studies show.
- Nightly use is where the trade-offs live. Tolerance builds, sleep can become more fragmented, and stopping brings rebound insomnia and vivid dreams for days to weeks.
- Judge products by evidence, not labels. "CBN for sleep" and high-dose CBD sleep claims are marketing positions, not findings.
- Next-day effects are usually mild but real. Trials report dry mouth and dizziness most often; one study found memory effects and increased sleepiness 10 hours after 15 mg THC. Plan accordingly, and never drive impaired.
- Persistent insomnia deserves a real workup. Insomnia that lasts for weeks is a medical symptom with effective, proven treatments — a clinician can help in ways a product cannot.
Ready to shop?
Browse our Pre-Rolls collection
Source notes
- • Morin et al. 2024, Sleep Medicine — Canadian survey (n=4,037) on cannabis-derived products used for sleep
- • Walsh et al. 2021, Sleep 44 — randomized crossover trial of a THC/CBN/CBD oil in insomnia (n=23)
- • Suraev et al. 2026, Journal of Sleep Research — single-dose THC+CBD sleep-lab study in insomnia (n=20)
- • Velzeboer et al. 2025, Sleep Medicine Reviews 84 — meta-analysis of polysomnography studies
- • Nicholson et al. 2004, Journal of Clinical Psychopharmacology — THC and THC+CBD effects on sleep and next-day performance (n=8)
- • Gorelick et al. 2013, American Journal on Addictions — tolerance to THC sleep effects in daily smokers (n=13)
- • Bahji et al. 2020, JAMA Network Open — cannabis withdrawal syndrome meta-analysis (47 studies, n=23,518)
- • Connor et al. 2022, Addiction — clinical features and time course of cannabis withdrawal
- • Vandrey et al. 2011, Drug and Alcohol Dependence — sleep-lab study of cannabis abstinence (n=20)
- • Shannon et al. 2019, The Permanente Journal — CBD case series in anxiety and sleep (n=72)
- • Linares et al. 2018, Frontiers in Pharmacology — CBD 300 mg and the sleep-wake cycle (n=26)
- • Narayan et al. 2024, Journal of Clinical Sleep Medicine — CBD 150 mg vs placebo in insomnia (n=30)
- • da Silva et al. 2025 — meta-analysis of cannabinoids and subjective sleep quality (6 RCTs, n=1,077)
- • Corroon 2021, Cannabis and Cannabinoid Research — evidence review of CBN and sleep
- • Bonn-Miller et al. 2024, Experimental and Clinical Psychopharmacology — CBN 20 mg RCT (n=293)
- • Kolobaric et al. 2024, Pharmaceuticals — CBN dose-ranging trial (n=1,020)
- • Varela et al. 2026, Cochrane Database of Systematic Reviews CD016216 — cannabinoids for insomnia (9 RCTs, n=537)
- • Suraev et al. 2020, Sleep Medicine Reviews — cannabinoids for sleep disorders review
- • Vu et al. 2026, JAMA Network Open — CARDIA 35-year cohort, cannabis use and sleep measures (n=1,266)

